Peter J. Thornton serves as Executive at AVADEL PHARMACEUTICALS PLC, where they oversee executive responsibilities. Since joining the company, Peter J. Thornton has executed 5 insider transactions totaling $134.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 29, 2025 involved receiving (via award) 11,000 shares valued at $0.
Peter J. Thornton currently holds 115,055 shares of AVADEL PHARMACEUTICALS PLC (AVDL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter J. Thornton has been a net buyer of AVDL stock. They have purchased $134.7K and sold $0 worth of shares.
Peter J. Thornton's most recent insider trade was on Jul 29, 2025, when they sold 11,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 27, 2022 | AVDL | $84.5K | Purchase | 50,000 | $1.69 | Discretionary |
| Aug 1, 2018 | AVDL | $0 | Award | 27,900 | $N/A | Discretionary |
| Sep 21, 2017 | AVDL | $50.2K | Purchase | 5,155 | $9.74 | Discretionary |